Evidence map›Paper›PMID 30762089›Full record

ArticlePsychopharmacology2019

Chronic administration of the histamine H

Alberto Avila-Luna, Camilo Ríos, Arturo Gálvez-Rosas, Sergio Montes, José-Antonio Arias-Montaño, Antonio Bueno-Nava

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. The Interaction of Histamine HPharmaceuticals (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Alberto Avila-LunaLab. Neurofisiología Química de la Discapacidad, División de Neurociencias, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, SSa, Calz. México-Xochimilco 289, 14389, Mexico City, Mexico.
Camilo RíosDepartamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, SSa, Insurgentes Sur 3877, 14269, Mexico City, Mexico.
Arturo Gálvez-RosasLab. Neurofisiología Química de la Discapacidad, División de Neurociencias, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, SSa, Calz. México-Xochimilco 289, 14389, Mexico City, Mexico.
Sergio MontesDepartamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, SSa, Insurgentes Sur 3877, 14269, Mexico City, Mexico.
José-Antonio Arias-MontañoDepartamento de Fisiología, Biofísica y Neurociencias, Centro de Investigación y de Estudios Avanzados del IPN, Av. IPN 2508, 07360, Mexico City, Mexico.
Antonio Bueno-NavaLab. Neurofisiología Química de la Discapacidad, División de Neurociencias, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, SSa, Calz. México-Xochimilco 289, 14389, Mexico City, Mexico. abueno@inr.gob.mx.
Instituto Nacional de Rehabilitación · MXInstituto Nacional de Neurología y Neurocirugía · MXInstituto Politécnico Nacional · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleHistamine H OBJECTIVES AND

methodsWe examined whether the chronic administration of the H

resultsThe systemic administration (i.p.) of L-Dopa for 14 days significantly increased axial, limb, and orolingual abnormal involuntary movements (AIMs) compared with the vehicle group. The chronic administration of the H

conclusionsThese results indicate that chronic H

Indexed as

AnimalsCorpus StriatumDyskinesia, Drug-InducedHistamine AgonistsImidazolesLevodopaMaleOxidopaminePiperidinesRatsRats, WistarReceptors, Histamine H3Substantia Nigra4-(1H-imidazol-4-ylmethyl)piperidineHistamine AgonistsImidazolesLevodopaOxidopaminePiperidinesReceptors, Histamine H3D1 receptorDopamineDyskinesiaH3 receptorHistamineImmepipL-DopaParkinson’s diseaseStriatum

Identifiers

PMID30762089
OpenAlexW2914869421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.